Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1999 Jun;54(6):488–492. doi: 10.1136/thx.54.6.488

Effects of inhaled β agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma

R Hancox 1, D Stevens 1, I Adcock 1, P Barnes 1, D Taylor 1
PMCID: PMC1745486  PMID: 10335001

Abstract

BACKGROUND—Inhaled corticosteroids and β agonists are the most commonly used treatments in asthma and are often used together. Recent evidence suggests that many of the anti-inflammatory actions of corticosteroids are mediated by cross-talk between the activated glucocorticoid receptor (GR) and other transcription factors such as the pro-inflammatory nuclear factor kappa B (NFκB). Beta agonists can activate the transcription factor cAMP response element binding protein (CREB). A mutual inhibition between GR and CREB occurs in vitro which raises the possibility of a negative interaction between corticosteroid and β agonist drugs. A study was undertaken to determine whether these interactions occur during treatment with β2 agonists and corticosteroids in asthma.
METHODS—Seven subjects who were participating in a randomised, placebo controlled, crossover study of six weeks treatment with inhaled budesonide (400 µg twice daily), terbutaline (1 mg four times daily), and combined treatment were recruited. Biopsy samples of the bronchial mucosa were obtained after each treatment and analysed for the DNA binding activity of GR, CREB, and NFκB.
RESULTS—Budesonide increased GR activity (p<0.05) and decreased NFκB activity (p<0.05). No treatment combination altered CREB activity and terbutaline had no significant effects on any transcription factor.
CONCLUSIONS—Inhaled corticosteroids have significant effects on GR and NFκB activity in bronchial mucosa. A negative interaction between inhaled corticosteroids and β agonists was not found.



Full Text

The Full Text of this article is available as a PDF (160.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adcock I. M., Brown C. R., Gelder C. M., Shirasaki H., Peters M. J., Barnes P. J. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol. 1995 Feb;268(2 Pt 1):C331–C338. doi: 10.1152/ajpcell.1995.268.2.C331. [DOI] [PubMed] [Google Scholar]
  2. Adcock I. M., Lane S. J., Brown C. R., Lee T. H., Barnes P. J. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med. 1995 Dec 1;182(6):1951–1958. doi: 10.1084/jem.182.6.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adcock I. M., Shirasaki H., Gelder C. M., Peters M. J., Brown C. R., Barnes P. J. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci. 1994;55(14):1147–1153. doi: 10.1016/0024-3205(94)00243-6. [DOI] [PubMed] [Google Scholar]
  4. Akerblom I. E., Slater E. P., Beato M., Baxter J. D., Mellon P. L. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science. 1988 Jul 15;241(4863):350–353. doi: 10.1126/science.2838908. [DOI] [PubMed] [Google Scholar]
  5. Auphan N., DiDonato J. A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995 Oct 13;270(5234):286–290. doi: 10.1126/science.270.5234.286. [DOI] [PubMed] [Google Scholar]
  6. Barnes P. J. Mechanisms of action of glucocorticoids in asthma. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 2):S21–S27. doi: 10.1164/ajrccm/154.2_Pt_2.S21. [DOI] [PubMed] [Google Scholar]
  7. Bellingham D. L., Sar M., Cidlowski J. A. Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol Endocrinol. 1992 Dec;6(12):2090–2102. doi: 10.1210/mend.6.12.1491690. [DOI] [PubMed] [Google Scholar]
  8. Brostjan C., Anrather J., Csizmadia V., Stroka D., Soares M., Bach F. H., Winkler H. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem. 1996 Aug 9;271(32):19612–19616. doi: 10.1074/jbc.271.32.19612. [DOI] [PubMed] [Google Scholar]
  9. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  10. Cockcroft D. W., Swystun V. A., Bhagat R. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1485–1489. doi: 10.1164/ajrccm.152.5.7582281. [DOI] [PubMed] [Google Scholar]
  11. Hancox R. J., Cowan J. O., Flannery E. M., Herbison G. P., McLachlan C. R., Wong C. S., Taylor D. R. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma. Thorax. 1999 Jun;54(6):482–487. doi: 10.1136/thx.54.6.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Heck S., Bender K., Kullmann M., Göttlicher M., Herrlich P., Cato A. C. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J. 1997 Aug 1;16(15):4698–4707. doi: 10.1093/emboj/16.15.4698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Imai E., Miner J. N., Mitchell J. A., Yamamoto K. R., Granner D. K. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem. 1993 Mar 15;268(8):5353–5356. [PubMed] [Google Scholar]
  14. Janknecht R., Hunter T. Versatile molecular glue. Transcriptional control. Curr Biol. 1996 Aug 1;6(8):951–954. doi: 10.1016/s0960-9822(02)00636-x. [DOI] [PubMed] [Google Scholar]
  15. Kalinyak J. E., Dorin R. I., Hoffman A. R., Perlman A. J. Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone. J Biol Chem. 1987 Aug 5;262(22):10441–10444. [PubMed] [Google Scholar]
  16. Korn S. H., Wouters E. F., Wesseling G., Arends J. W., Thunnissen F. B. In vitro and in vivo modulation of alpha- and beta-glucocorticoid-receptor mRNA in human bronchial epithelium. Am J Respir Crit Care Med. 1997 Mar;155(3):1117–1122. doi: 10.1164/ajrccm.155.3.9116996. [DOI] [PubMed] [Google Scholar]
  17. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem. 1994 May 6;269(18):13289–13295. [PubMed] [Google Scholar]
  18. Peters M. J., Adcock I. M., Brown C. R., Barnes P. J. Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol. 1995 Apr 28;289(2):275–281. doi: 10.1016/0922-4106(95)90104-3. [DOI] [PubMed] [Google Scholar]
  19. Ray A., Prefontaine K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):752–756. doi: 10.1073/pnas.91.2.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rosewicz S., McDonald A. R., Maddux B. A., Goldfine I. D., Miesfeld R. L., Logsdon C. D. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem. 1988 Feb 25;263(6):2581–2584. [PubMed] [Google Scholar]
  21. Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S., Jr Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995 Oct 13;270(5234):283–286. doi: 10.1126/science.270.5234.283. [DOI] [PubMed] [Google Scholar]
  22. Schüle R., Rangarajan P., Kliewer S., Ransone L. J., Bolado J., Yang N., Verma I. M., Evans R. M. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 1990 Sep 21;62(6):1217–1226. doi: 10.1016/0092-8674(90)90397-w. [DOI] [PubMed] [Google Scholar]
  23. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994;10:405–455. doi: 10.1146/annurev.cb.10.110194.002201. [DOI] [PubMed] [Google Scholar]
  24. Svec F. The biopotency of dexamethasone at causing hepatic glucocorticoid receptor down-regulation in the intact mouse. Biochim Biophys Acta. 1988 Jun 8;970(1):90–95. doi: 10.1016/0167-4889(88)90226-1. [DOI] [PubMed] [Google Scholar]
  25. Wong C. S., Wahedna I., Pavord I. D., Tattersfield A. E. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1268–1273. doi: 10.1164/ajrccm.150.5.7952551. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES